miDiagnostics

miDiagnostics is a Belgian company focused on advanced diagnostic technology. Founded in 2015 as a spin-out from imec, the company collaborates with Johns Hopkins University to develop miniaturized, rapid diagnostic tests that deliver lab-quality results directly to patients and clinicians. Their core innovation is a proprietary silicon chip embedded in a disposable PCR card, enabling ultra-fast polymerase chain reaction (PCR) testing with minimal sample volumes. The technology supports decentralized, point-of-care diagnostics, making it suitable for various settings, including community health centers and homes. miDiagnostics is creating a portfolio of molecular diagnostic tests for a range of health conditions, emphasizing speed, reliability, and ease of use. Their solutions aim to reduce testing costs and provide near-immediate results, facilitating timely clinical decisions. Headquartered in Leuven, Belgium, miDiagnostics employs over 100 people and has raised approximately $32 million in funding.

• Employees61
• Founded2015
• Annual Revenue$1000000
• Total Funding$48870790